Phototoxic eruptions due to doxycycline-a dose-related phenomenon
- 1 May 1993
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 18 (5) , 425-427
- https://doi.org/10.1111/j.1365-2230.1993.tb02242.x
Abstract
The tetracycline group of antibiotics still remains the most successful oral treatment for acne. They are relatively free from side-effects apart from the occasional gastrointestinal upset or vaginal candidosis. Rarer side-effects include drug rashes,1 pigmentation with minocycline2 and a light-sensitive eruption with doxycycline.3,4 The incidence of light-sensitive rashes with doxycycline at a dose of 100 mg daily, is in the order of 3%.5 Acne does not always respond to conventional regimens of antibiotics and higher dosages may be required.6 We report a highly significant incidence of light-sensitive eruptions in patients receiving doxycycline at a daily dose of 150 mg or above.Keywords
This publication has 9 references indexed in Scilit:
- Unusual side-effects in patients receiving doxycyclineJournal of Dermatological Treatment, 1989
- A comparison of doxycycline and minocycline in the treatment of acne vulgarisClinical and Experimental Dermatology, 1988
- Increased Frequency of Doxycycline Side EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
- Therapy of AcneMedical Clinics of North America, 1982
- Cutaneous pigmentation due to minocycline hydrochlorideJournal of the American Academy of Dermatology, 1980
- Safety of long-term tetracycline therapy for acneArchives of Dermatology, 1976
- Phototoxic potential of minocycline and doxycyclineArchives of Dermatology, 1972
- Photo-onycholysis due to tetracycline hydrochloride and doxycyclineArchives of Dermatology, 1971
- Photosensitivity studies with demethylchlortetracycline and doxycyclineArchives of Dermatology, 1968